Completed OBSERVATIONAL NCT03252990

18F-fluorocholine PET-MR Imaging of Coronary Plaque Vulnerability

Molecular Imaging of Coronary Plaque Vulnerability Using 18F-fluorocholine PET-MRI in Patients With Coronary Artery Disease

Sponsor: Maastricht University Medical Center

Conditions Atherosclerosis Coronary Artery Disease Coronary Stenosis Heart Attack Multi Vessel Coronary Artery Disease Myocardial Infarction Myocardial Ischemia

Interventions Optical Coherence Tomography PET-MRI

Updated 8 times since 2017 Last updated: Feb 19, 2020 Started: Mar 2, 2018 Primary completion: Dec 6, 2019 Completion: Dec 6, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Atherosclerosis and Coronary Artery Disease and is currently completed. Maastricht University Medical Center leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Mar 2020 — Jan 2021 [monthly]

Completed

Status: Recruiting → Completed
Sep 2018 — Mar 2020 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting

▶ Show 3 earlier versions

Jun 2018 — Sep 2018 [monthly]

Not Yet Recruiting
Apr 2018 — Jun 2018 [monthly]

Not Yet Recruiting

Phase: NA → None
Sep 2017 — Apr 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Maastricht University Medical Center
Stichting de Weijerhorst
VieCuri Medical Centre

Data source: Maastricht University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Maastricht, Netherlands